NCT04337268View on ClinicalTrials.gov

Acute Effects of GLP-1 on Renal Hemodynamics

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
The GLP-1-mediated Gut-kidney Axis
Interventions
DRUG

Glucagon-Like Peptide 1

Intravenous infusion (1.5 pmol/kg/min) for 60 min.

DRUG

saline 0.9%

Intravenous infusion for 60 min.

Trial Locations (1)

2600

Rigshospitalet - Glostrup, Glostrup Municipality

All Listed Sponsors
collaborator

Department of Cardiovascular and Renal Research, University of Southern Denmark

UNKNOWN

lead

Rigshospitalet, Denmark

OTHER

NCT04337268 - Acute Effects of GLP-1 on Renal Hemodynamics | Biotech Hunter | Biotech Hunter